Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
Public ClinicalTrials.gov record NCT01078389. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Phase 2 Study to Evaluate the Effect of Febuxostat Versus Placebo in Joint Damage in Hyperuricemic Subjects With Early Gout
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This purpose of this study is to assess the effect of febuxostat, once daily (QD), on joint damage in patients with elevated serum urate levels and gout.
Study identification
- NCT ID
- NCT01078389
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 314 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2010 (Type not available)
- Primary completion
- Sep 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Sep 10, 2014
2010 – 2013
United States locations
- U.S. sites
- 56
- U.S. states
- 27
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mesa | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Burbank | California | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Rancho Cucamonga | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | San Luis Obispo | California | — | — |
| Not listed | Trumbull | Connecticut | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Sanford | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Arlington Heights | Illinois | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Greenfield | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Rockport | Maine | — | — |
| Not listed | Chaska | Minnesota | — | — |
| Not listed | Belzoni | Mississippi | — | — |
| Not listed | Olive Branch | Mississippi | — | — |
| Not listed | Billings | Montana | — | — |
| Not listed | Missoula | Montana | — | — |
| Not listed | Bellevue | Nebraska | — | — |
| Not listed | Henderson | Nevada | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Lenoir | North Carolina | — | — |
| Not listed | Shelby | North Carolina | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Franklin | Ohio | — | — |
| Not listed | Willoughby Hills | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | East Providence | Rhode Island | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Southlake | Texas | — | — |
| Not listed | Sugar Land | Texas | — | — |
| Not listed | Arlington | Virginia | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
| Not listed | Kenosha | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01078389, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2014 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01078389 live on ClinicalTrials.gov.